KRM Ayurveda IPO Details
KRM Ayurveda IPO Summary
KRM Ayurveda IPO opens for subscription on 21 Jan 2026 and closes on 23 Jan 2026.The IPO will be listed on NSE with the tentative listing date set for 29 Jan 2026.
KRM Ayurveda IPO price band has been fixed at ₹128 – ₹135 per share. The face value is ₹10 per share with a lot size of 1000.
KRM Ayurveda IPO total issue size comprises 57,40,000 shares (aggregating up to ₹77.49 Cr.). This includes a fresh issue of 57,40,000 shares (aggregating up to ₹77.49 Cr.). Pre-issue shareholding stands at 1,55,20,800, which will increase to 2,12,60,800 post-issue.
KRM Ayurveda IPO carries a ₹22.5 (16.67%) GMP, reflecting investor sentiment.
KRM Ayurveda IPO Lot Size :Individual Minimum is 2 lots (2,000 shares) amounting to ₹270,000. Individual Maximum is 2 lots (2,000 shares) amounting to ₹270,000. SHNI Minimum is 3 lots (3,000 shares) amounting to ₹405,000. SHNI Maximum is 7 lots (7,000 shares) amounting to ₹945,000. BHNI Minimum is 8 lots (8,000 shares) amounting to ₹1,080,000.
The Lead Managers for KRM Ayurveda IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Nexgen Capitals Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Mansi Share & Stock Broking Pvt Ltd, Nikunj Stock Brokers. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the KRM Ayurveda Limited RHP.
KRM Ayurveda IPO Details
KRM Ayurveda IPO Subscription
KRM Ayurveda IPO Application Wise Breakup
KRM Ayurveda IPO Dates
- 21 Jan 2026Opening dateOpen
- 23 Jan 2026Closing dateClose
- 27 Jan 2026Allotment Date Allotment
- 28 Jan 2026Initiation of RefundsRefund
- 28 Jan 2026Credit of SharesCredit
- 29 Jan 2026Listing dateListing
KRM Ayurveda IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2000 | ₹270,000 |
| Individual Maximum | 2 | 2000 | ₹270,000 |
| SHNI Minimum | 3 | 3000 | ₹405,000 |
| SHNI Maximum | 7 | 7000 | ₹945,000 |
| BHNI Minimum | 8 | 8000 | ₹1,080,000 |
KRM Ayurveda IPO Reservation
Promoter Holding
Documents
KRM Ayurveda IPO Valuations
KRM Ayurveda Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
| Amount in ₹ Crore | ||||
About KRM Ayurveda IPO
Incorporated on September 3, 2019, KRM Ayurveda Limited is an Ayurveda-focused healthcare company engaged in the operation of hospitals and clinics across multiple cities in India, while also extending its presence internationally through telemedicine consultations and product sales.
The Company follows an integrated healthcare model combining clinical services and Ayurvedic product offerings. It is engaged in the manufacture and sale of Ayurvedic medicines, herbal and botanical formulations, dietary supplements, and wellness-oriented products, which may include skincare and preventive healthcare solutions, marketed under the KRM Ayurveda brand.
As of August 31, 2025, the Company operated a network of six (6) hospitals and five (5) clinics at various locations across India, providing Ayurveda-based diagnosis, treatment, and wellness services. In addition, the Company offers teleconsultation services, enabling access to its Ayurvedic practitioners and products for patients in India and overseas.
KRM Ayurveda’s service portfolio includes:
Hospital-based Ayurvedic healthcare services
Clinic-based outpatient consultation and treatment
Telemedicine consultation services
Manufacturing and sale of KRM Ayurveda branded products
As of August 31, 2025, the Company employed a total of 429 employees across medical, administrative, manufacturing, sales, and support functions, supporting its operations and growth initiatives.
Strength Of KRM Ayurveda IPO
- Designing and execution capabilities.
- Experienced management team and a motivated and efficient work force.
- Cordial relations with our consumers.
- Quality assurance and control.
Risk Of KRM Ayurveda IPO
- The company's Registered Office and other hospital premises from where the company operates are not owned by the company. If the company are required to vacate the same, due to any reason whatsoever, it may adversely affect its business operations.
- The Company has experienced, and may continue to experience, a higher rate of employee attrition in recent periods, including among frontline and technical staff.
- Majority of its state wise revenues from operations for the last 3 years is majorly derived from the company's Top 2 States. Any adverse developments affecting its operations in this state could have an adverse impact on the company's revenue and results of operations.
- The company's business is working capital intensive, and fluctuations or inadequate financing of its working capital requirements may adversely affect the company's business, financial condition, and results of operations.
- The company is dependents on third-party transportation service providers for delivery of its raw materials and finished products. Any disruption in such transportation arrangements or increase in transportation costs may materially and adversely affect the company's business, financial condition, results of operations, and cash flows
- Conflicts of interest may arise out of common business undertaken by the Company and its promoter.
- The provision of healthcare services involves high costs such as employee benefit expenses, rent and facility fees, retainers and consultants fee and purchase of equipment and consumables, which the company may fails to pass on to patients, which could adversely affect its business, results of operations and financial condition.
- A significant portion of its revenue is derived from patients who avail the company's hospital services through insurance providers. Any adverse change in the relationship with such insurers, delay in settlement of claims, or reduction in reimbursement rates may materially and adversely affect its business, financial condition, results of operations, and cash flows.
- The intend to use a portion of the Net Proceeds to prepay / repay in full or in part, of certain borrowings availed by the Company
- Declining Reimbursement Rates from insurance providers may affect its financial position.
Objectives KRM Ayurveda IPO
1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
2. Purchase of CRM Software and Hardware Infrastructure
3. Human Resources
4. Repayment/Prepayment of loan
5. Working Capital Requirement
6. General Corporate Purposes
Company Contact Details
KRM Ayurveda Ltd.
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
Phone: +91- 9289101700
Email: compliance@krmayurveda.com
Website: http://www.krmayurvedaindia.com/
Registrar Contact Details
KRM Ayurveda FAQs
The KRM Ayurveda IPO is a SME public issue comprising 5740000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹77.49 Cr.. The issue price has been fixed at ₹135 per equity share, and the minimum application size is 1000 shares.
The IPO opens for subscription on 21 Jan 2026, and closes on 23 Jan 2026.
Skyline Financial Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE
As of now, the current GMP stands at ₹22.5 (16.67%).
Quick Links
Comments
